Latest Philadelphia chromosome Stories
Omacetaxine launches different attack on CML that is impervious to other therapies.
NEW ORLEANS, Dec. 5 /PRNewswire-USNewswire/ -- Leukemia and myeloproliferative disorders are serious and often deadly blood cancers.
NEW YORK, Dec.
SOUTH SAN FRANCISCO, Calif., Dec. 1 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc.
Kareem Abdul-Jabbar, one of the greatest basketball players of all time, known for his unblockable signature "sky hook" shot, has announced that he was diagnosed late last year with a rare type of blood cancer known as Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).
EAST HANOVER, N.J., Oct. 20 /PRNewswire/ -- Novartis announced today that TasignaÂ® (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug GleevecÂ® (imatinib mesylate) tablets*.
Phase 2 study results of targeted therapy added to chemo.
NEW YORK, Sept.
University of Michigan researchers have developed an animal model that provides strong evidence why imatinib, marketed as Gleevec, helps patients with chronic myeloid leukemia survive longer, but does not keep the disease from returning if treatment ends.
Oncology Test Further Highlights Broad Market Applicability of GeneXpert System SUNNYVALE, Calif., June 17 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced the release of its improved Xpert(R) BCR-ABL Monitor test to be marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices.
- To fire mitraille at.